Hmm....With protons, 5-year ORN rate is 14.4% in oropharynx, 9.9% in oral cavity, and 11.5% combined.
Authors point to higher RBE of protons as one possibility. Credit to them for sharing and publishing this, would love a podcast discussion
#radonc
Radiotherapy 🏥is an often poorly understood
#cancer
treatment.
But it is an essential, life saving treatment that >50% of all people will cancer 🦀 will benefit from.
Here's how you can advocate for your loved ones in 4 easy steps: a thread🧵
#radonc
1/692
The DEBRA Study, NRG-BR007, will be checking to see if treatment with hormonal therapy alone is the same as the usual treatment of radiation and hormonal therapy in women with low-risk, hormone-sensitive
#breastcancer
who have had a lumpectomy. Learn more:
I've been waiting for a piece like this for a long time.
Surgeons often sacrifice tissues/organs to remove the tumor
Medoncs accept 50% grade 3-5 AE for immunotherapy (), and yet
1/2
#radonc
Aggregate safety data for pembrolizumab monotherapy across trials in European Journal of Cancer with Dr.
@JulieBrahmer
et al (n=8937). G3+ AEs in 51% of pts, discontinuation from AE in 13%, fatal AEs 6%. Median time to immune-mediated AE was 85d.
@drmattmc
Yup. The priorities for men are to preserve function whereas the priorities for women are set by leaders with their own “priorities” (ego, career, fame, money), rather than to try to help the patients suffering from breast cancer.
If we did a survey asking what these women
Some radoncs have not learned sometimes the worst toxicity is the tumor. There should be nuance in how constraints are applied case to case, when to violate/sacrificewhen to respect.
We need a new paradigm in precision RT. You can't make a Jedi with stormtrooper energy
Great to see the awaited results of
@NRGonc
RTOG0920 evaluating the addition of cetuximab to adj RT in int risk HNSCC. Improved 3yr DFS 78.3% vs 71.5% HR 0.75, but not OS. Anticipated ⬆️ acute toxicity but similar long term.
@ShlomoKoyfmanMD
@ajacobmiller
@JLGeigerMD
@YilmazMDPhD
Me watching an alternate reality where radoncs get their act together and innovate cancer care fast rather than do the same dumb studies of dose/fx comparisons and making dumb arguments no other specialty cares about.
#victimmentality
#lookinthemirror
#radonc
Absolutely terrific thread here on ENI dosing for oropharyngeal cancer, touching not just on recent data but on how new standards are established.
Just a few thoughts on top of well-articulated arguments for different approaches. (1/n)
"look at those trouble makers giving radiation without level randomized evidence powered for OS"
- radonc who let's patient with single site of recurrence get chemo for a year
#stateoftheunion
#radonc
Hot off the press in
@IJROBP
: the ARREST phase I trial of SABR in poly-metastatic disease, led by
@lhscradonc
&
@TimkWin
Average number of lesions = 16
Dose safely escalated to 30 Gy in 5 fractions.
The phase II/III RCT ARREST2 is underway!
Yesterday, we activated two new RCTs of SABR in the oligo/poly-metastatic space.
This one below is SABR-SYNC, enrolling patients with up to 10 metastases and a synchronous primary tumor. It's a phase III, primary endpoint is OS.
Hi everyone,
I am deeply sorry for all my memes and if they have hurt anyone's feelings.
I have realized the error of my ways and this will now be strictly a proton appreciation account from now on.
Best,
sbrtmemes
MD =/= good leader
Often we promote renowned researchers to leadership posts and assume they can lead well
Leadership is one of the hardest skills and needs a team that can criticise leaders without retaliation
#radonc
#benchtobedsidetoanothercenter
🛑🛑🛑Here is our STOP RCT looking at SABR in patients with oligoprogressive cancers, just published in
@ijrobp
We learned a few important lessons for clinical practice and for the design of future trials...(thread 👇)
How did 2Gy/fraction become standard in RT?
Answer: ram testicles.
Lab work done by the French showed less skin/sterility issues with 2Gy to ram testicles vs bigger fractions.
Much of the dogma in our field is based upon strong opinions, urban legend...& livestock lab data.